Back to journals
Academic Journal

Expert Review of Neurotherapeutics

2 Papers Indexed in Blossom

Data updated

Research Footprint

Expert Review of Neurotherapeutics has 2 tracked papers indexed in Blossom (2016–2020) from 18 authors, most often covering Psilocybin and MDMA, across Depressive Disorders, Alcohol Use Disorder (AUD) and Tobacco/Nicotine Use Disorder (TUD).

Published Papers

Paywallmeta

The Emerging Role of Psilocybin and MDMA in the Treatment of Mental Illness

This narrative review (2020) evaluates the therapeutic potential of psilocybin and MDMA for the treatment of major depressive disorder (MDD), post-traumatic stress disorder (PTSD), and anxiety. The review explains the need for effective mental health treatments and highlights the lack of dose-response studies in placebo-controlled settings with a real-world clinical population.

Published
Journal
Expert Review of Neurotherapeutics
Authors
Gill, H., Gill, B., Chen-Li, D., El-Halabi, S., Rodrigues, N. B., Cha, D. S., Lipsitz, O., Lee, Y., Rosenblat, J. D., Majeed, A., Mansur, R. B., Nasri, F., Ho, R., Mcintyre, R. S.
Open Accessmeta

Psilocybin for treating substance use disorders?

This study (2017) reviews the human evidence regarding psilocybin as a potential treatment for substance use disorders (SUD). The authors conclude that the evidence thus far seems promising, but will need to be confirmed in future studies.

Published
Journal
Expert Review of Neurotherapeutics
Authors
de Veen, B. T. H., Schellekens, A., Verheij, M. M., Homberg, J. R.

Quick Facts

Papers Indexed
2
h-Index
103
Open Access
No
Publisher
Taylor & Francis
Country
United Kingdom
Website
Visit